Trial Profile
A randomised phase II trial of letrozole +/- metronomic cyclophosphamide as primary systemic treatment in elderly patients with breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Letrozole (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 25 Nov 2015 New trial record